[Advantages and hazards of thyrostatic therapy without thyroid hormones in diffuse hyperthyroidism].
D002231:Carbimazole / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D005094:Exophthalmos / Q000175:diagnosis; D005500:Follow-Up Studies; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy*; D008713:Methimazole / Q000627:therapeutic use*; D013963:Thyroid Hormones / Q000627:therapeutic use*; D013972:Thyrotropin / Q000097:blood; D013974:Thyroxine / Q000097:blood
D013963:Thyroid Hormones; D008713:Methimazole; D002231:Carbimazole; D013972:Thyrotropin; D013974:Thyroxine
Vorteile und Gefahren einer thyreostatischen Therapie der diffusen Hyperthyreose ohne Schilddrüsenhormone.